NAA10, N-alpha-acetyltransferase 10, NatA catalytic subunit, 8260
N. diseases: 199; N. variants: 15
Source: ALL
| Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
G | 0.840 | CausalMutation | CLINVAR | |||||||||
|
|
|
G | 0.810 | CausalMutation | CLINVAR | |||||||||
|
|
|
G | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
C | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
0.840 | GeneticVariation | UNIPROT | Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. | 21700266 | 2011 | |||||||
|
|
|
0.810 | GeneticVariation | UNIPROT | Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. | 21700266 | 2011 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | The -374T/A and -429T/C did not show positive interaction with obesity and smoking status. | 22987041 | 2012 | |||||||
|
|
|
0.840 | GeneticVariation | BEFREE | A single hypomorphic missense variant p.(Ser37Pro) was previously associated with Ogden syndrome in eight affected males from two different families. | 25099252 | 2015 | |||||||
|
|
|
0.840 | GeneticVariation | UNIPROT | Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects. | 25489052 | 2015 | |||||||
|
|
|
0.810 | GeneticVariation | UNIPROT | Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects. | 25489052 | 2015 | |||||||
|
|
|
0.840 | GeneticVariation | BEFREE | Our findings expand the clinical spectrum of NAA10 and suggest that the proposed correlation between mutant Naa10 enzyme activity and phenotype severity is more complex than anticipated; the p.Tyr43Ser mutant enzyme has less catalytic activity than the p.Ser37Pro mutant associated with lethal Ogden syndrome but results in a milder phenotype. | 26522270 | 2015 | |||||||
|
|
|
0.840 | GeneticVariation | UNIPROT | Our findings expand the clinical spectrum of NAA10 and suggest that the proposed correlation between mutant Naa10 enzyme activity and phenotype severity is more complex than anticipated; the p.Tyr43Ser mutant enzyme has less catalytic activity than the p.Ser37Pro mutant associated with lethal Ogden syndrome but results in a milder phenotype. | 26522270 | 2015 |